French study to reveal true COVID-19 infection rates during lockdown easing
NCT ID NCT04429594
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is following 1,000 people in the Alpes-Maritimes region of France to see how many were infected with the coronavirus during the deconfinement period. Researchers are using blood tests to measure immune responses and will also look at how air pollution might affect the immune system. The goal is to better understand the spread of the virus and its impact on health.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could provide a clearer picture of how many people were infected with COVID-19 and how their immune systems responded, helping guide public health decisions.
- What could go wrong
- This is an observational study, not a treatment trial. It cannot prove cause and effect, and results may be influenced by factors like seasonality or changes in behavior.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONAVIRUS INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Nice Hospital
RECRUITINGNice, 06000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New vaccine aims to shield against multiple coronaviruses at once
- Massive COVID-19 biobank aims to unlock secrets of severe disease
- Real-World data on CPAP for COVID-19 respiratory failure
- Could a simple gas shield healthcare workers from COVID-19?
- Could a simple gas stop COVID-19 from getting worse?
- Tiny study probes how COVID shots alter immune cell activity